Anticancer nanodelivery system with controlled release property based on protocatechuate–zinc layered hydroxide nanohybrid

Abstract

Background We characterize a novel nanocomposite that acts as an efficient anticancer agent. Methods This nanocomposite consists of zinc layered hydroxide intercalated with protocatechuate (an anionic form of protocatechuic acid), that has been synthesized using a direct method with zinc oxide and protocatechuic acid as precursors. Results The resulting protocatechuic acid nanocomposite (PAN) showed a basal spacing of 12.7 Å, indicating that protocatechuate was intercalated in a monolayer arrangement, with an angle of 54° from the Z-axis between the interlayers of the zinc layered hydroxide, and an estimated drug loading of about 35.7%. PAN exhibited the properties of a mesoporous type material, with greatly enhanced thermal stability of protocatechuate as compared to its free counterpart. The presence of protocatechuate in the interlayers of the zinc layered hydroxide was further supported by Fourier transform infrared spectroscopy. Protocatechuate was released from PAN in a slow and sustained manner. This mechanism of release was well represented by a pseudo-second order kinetics model. PAN has shown increased cytotoxicity compared to the free form of protocatechuic acid in all cancer cell lines tested. Tumor growth suppression was extensive, particularly in HepG2 and HT29 cell lines. Conclusion PAN is suitable for use as a controlled release formulation, and our in vitro evidence indicates that PAN is an effective anticancer agent. PAN may have potential as a chemotherapeutic drug for human cancer.

Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy

“…4), and Korsmeyer-Peppas Model (Eq. 5) [53, 54]. The equations are shown below where k is the corresponding release amount constant, q e and q t are the equilibrium release amount and the release amount at time t , respectively, and M 0 and M t represent the drug (GA) content remaining in the GO nanocarrier at release times 0 and t , respectively.…”

Impact of size, secondary structure, and counterions on the binding of small ribonucleic acids to layered double hydroxide nanoparticles

“…22 The Barahuie et al group successfully delivered two anticancer drugs, chlorogenic acid and protocatehuic acid, using modified hydrotalcite. 23 The adsorption capability of HT to single-and double-stranded DNA was evidenced by a previous study performed in this lab, which noted that adsorption was dependent on the conditions of synthesis of the HT as well as on the charge density of both the DNA molecules and the HT. 9 Li et al successfully transfected DNA plasmids encoding the enhanced green fluorescent protein into NSC 34 (mouse motor neuron cells).…”

Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system

“…62,63 The efficacy of PTA-CS-MNP nanocomposite in suppressing the growth of HT29 colorectal adenocarcinoma cells was assessed using colorimetric assay (MTT assay). The 3T3 normal fibroblast cells were employed as normal control to ensure the nontoxic nature of nanocomposite.…”